Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDSELLAS Life Sciences Group, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.17 | -$0.17 | -$0.17 |
| Q2 2024 | 1 | -$0.13 | -$0.13 | -$0.13 |
| Q3 2024 | 3 | -$0.12 | -$0.09 | -$0.11 |
| Q1 2025 | 2 | -$0.12 | -$0.11 | -$0.12 |
| Q2 2025 | 1 | -$0.11 | -$0.11 | -$0.11 |
| Q3 2025 | 1 | -$0.11 | -$0.11 | -$0.11 |
| Q4 2025 | 1 | -$0.11 | -$0.11 | -$0.11 |
SELLAS Life Sciences Group, Inc. Earnings Date And Information
SELLAS Life Sciences Group, Inc. last posted its earnings results on Tuesday, August 13th, 2024. The company reported $-0.13 earnings per share for the quarter, topping analysts' consensus estimates of $-0.16 by $0.03. The company had revenue of 0 for the quarter and had revenue of 0 for the year. SELLAS Life Sciences Group, Inc. has generated $-1 earnings per share over the last year ($-1.34 diluted earnings per share) and currently has a price-to-earnings ratio of -1.97. SELLAS Life Sciences Group, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 20th, 2025 based on prior year's report dates.
SELLAS Life Sciences Group, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2024 | Q3 2024 | -$0.10 | $0 | $0 | ||
| 08/13/2024 | Q2 2024 | -$0.16 | -$0.13 | 0.03 | $0 | $0 |
| 03/29/2024 | Q1 2024 | -$0.21 | $0 | |||
| 12/29/2023 | Q4 2023 | -$0.25 | $0 | |||
| 11/09/2023 | Q3 2023 | -$0.03 | -$0.33 | -0.3 | $13.00 M | $0 |
| 08/10/2023 | Q2 2023 | -$0.35 | -$0.31 | 0.04 | $0 | |
| 05/11/2023 | Q1 2023 | -$0.29 | -$0.46 | -0.17 | $0 | |
| 03/16/2023 | Q4 2022 | $0.32 | -$0.41 | -0.73 | $-1,000,000 | |
| 11/14/2022 | Q3 2022 | -$0.39 | -$0.33 | 0.06 | $0 | |
| 08/11/2022 | Q2 2022 | -$0.35 | -$0.40 | -0.05 | $0 | |
| 05/12/2022 | Q1 2022 | -$0.38 | -$1.05 | -0.67 | $1.00 M | |
| 03/31/2022 | Q4 2021 | -$0.42 | $-7,600,000 | |||
| 11/12/2021 | Q3 2021 | -$0.38 | -$0.45 | -0.07 | $0 | |
| 08/12/2021 | Q2 2021 | -$0.39 | -$0.30 | 0.09 | $1.90 M | |
| 05/13/2021 | Q1 2021 | -$0.27 | -$0.16 | 0.11 | $5.70 M | |
| 03/23/2021 | Q4 2020 | -$0.44 | $1.90 M | |||
| 11/13/2020 | Q3 2020 | -$0.53 | $0 | |||
| 08/13/2020 | Q2 2020 | -$0.64 | -$0.66 | -0.02 | $0 | |
| 05/14/2020 | Q1 2020 | -$0.65 | $0 | |||
| 03/13/2020 | Q4 2019 | -$0.72 | -$1.16 | -0.44 | $0 |
SELLAS Life Sciences Group, Inc. Earnings: FAQ's
When is SELLAS Life Sciences Group, Inc.'s earnings date?
SELLAS Life Sciences Group, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 20th, 2025 based off last year's report dates.
Did SELLAS Life Sciences Group, Inc. beat their earnings estimates last
quarter?
In the previous quarter, SELLAS Life Sciences Group, Inc. (:SLS) reported $-0.13 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.16 by $0.03.
How can I listen to SELLAS Life Sciences Group, Inc.'s earnings conference
call?
The conference call for SELLAS Life Sciences Group, Inc.'s latest earnings report can be listened to online.
How can I read SELLAS Life Sciences Group, Inc.'s conference call transcript?
The conference call transcript for SELLAS Life Sciences Group, Inc.'s latest earnings report can be read online.
How much profit does SELLAS Life Sciences Group, Inc. generate each year?
SELLAS Life Sciences Group, Inc. (:SLS) has a recorded net income of $0. SELLAS Life Sciences Group, Inc. has generated $-1.34 earnings per share over the last four quarters.
What is SELLAS Life Sciences Group, Inc.'s price-to-earnings ratio?
SELLAS Life Sciences Group, Inc. (:SLS) has a price-to-earnings ratio of -1.97 and price/earnings-to-growth ratio is -0.08.